4//SEC Filing
Lucera Erick 4
Accession 0000950170-25-048601
CIK 0001818794other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:33 PM ET
Size
7.2 KB
Accession
0000950170-25-048601
Insider Transaction Report
Form 4
Lucera Erick
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-03-31+214,500→ 214,500 totalExercise: $10.46Exp: 2035-03-30→ Common Stock (214,500 underlying) - Award
Common Stock
2025-03-31+66,100→ 66,100 total
Footnotes (2)
- [F1]Consists of shares of Common Stock issuable under 66,100 restricted stock units ("RSU"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest as to 25% of the shares in equal annual installments over four years with the first installment vesting on March 31, 2026, subject to continuous service.
- [F2]The option was granted on March 31, 2025. The shares underlying the option are scheduled to vest over four years, with 25% of the shares underlying the option vesting on March 31, 2026, and the remainder vesting in 12 equal quarterly installments thereafter, subject to continuous service.
Documents
Issuer
Dyne Therapeutics, Inc.
CIK 0001818794
Entity typeother
Related Parties
1- filerCIK 0001697616
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 4:33 PM ET
- Size
- 7.2 KB